+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

  • ID: 4622148
  • Report
  • September 2018
  • Region: Global
  • 219 Pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • Belimed
  • Merck
  • Pfizer
  • Sanofi, Sanofi Pasteur
  • Sterigenics
  • MORE

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g. catheters, patient ventilation devices, sterile IV filters) that prevent occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).

The Report Includes:

  • 42 data tables and 32 additional tables
  • Industry analysis of the global healthcare-acquired infection (HCAI) control market
  • Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections
  • Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections
  • Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections
  • A look at the hospital surveillance methods and tools currently being used to prevent these infections
  • Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries)
  • Information on key patents and newer research developments in sterilization systems and devices
  • Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur

Membership Price:

Contact us for membership Pricing.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • Belimed
  • Merck
  • Pfizer
  • Sanofi, Sanofi Pasteur
  • Sterigenics
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Healthcare-Acquired Infections
  • Types of Infections
  • Central-Line-Associated Bloodstream Infections
  • Surgical Site Infections
  • Catheter-Associated Urinary Tract Infections
  • Ventilator-Associated Pneumonia
  • Diseases and Infectious Agents in Healthcare Settings
  • Acinetobacter
  • Burkholderia cepacia
  • Clostridium difficile
  • Clostridium sordellii
  • Enterobacteriaceae (Carbapenem-Resistant)
  • Gram-Negative Bacteria
  • Hepatitis
  • HIV/AIDS
  • Influenza
  • Klebsiella
  • Methicillin-Resistant Staphylococcus aureus
  • Mycobacterium abscessus
  • Norovirus
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Vancomycin-Resistant Enterococci
  • Incidence and Prevalence
  • Risk Factors
  • Prevention Strategies
  • Basic Infection Prevention and Control
  • Antibiotics and Multidrug-Resistant Organisms
  • Device-Associated Infection Control
  • Procedure-Associated Guidelines
  • Setting Specific Guidelines
  • WHO Guidelines
  • Surveillance Systems

Chapter 4 Market Summary and Analysis

  • Global Infection control Market
  • Region-wise Analysis
  • Market Drivers
  • Antimicrobial Resistance
  • Increasing Population and Demographic Changes
  • Emerging Markets
  • New Technologies
  • Vaccine Coverage
  • Increase in Focus on HCAIs
  • Market Deterrents
  • Cost-Effectiveness of Newer Methods
  • Unmet Needs
  • Effective Treatment for "Superbugs"

Chapter 5 Pharmaceuticals

  • HCAI Pharmaceuticals Market
  • Antibiotics
  • Mechanism of Action
  • Antibiotics Resistance
  • Mechanisms of Antibiotic Resistance
  • Reasons for Antibiotic Resistance
  • Antimicrobial Resistance (Antibiotics) -- Incidence
  • Antibiotic Resistance -- Hospitals, Healthcare Settings
  • Davos Declaration for Combating Antimicrobial Resistance
  • Antibiotics for Bacterial HCAI
  • Select Marketed Antibiotics
  • Global Antibiotics Market
  • Antifungal Drugs
  • Antifungals for HCAI
  • Select Marketed Antifungals
  • Global Antifungals Market
  • Antivirals and Vaccines
  • Hepatitis B and Hepatitis C
  • Influenza

Chapter 6 Environmental Treatment

  • HCAI: Environmental Treatment Market
  • Disinfectants
  • Key Marketed Hospital-Use Disinfectants
  • Patient Skin Preparation
  • Key Marketed Patient Skin Preparation Antiseptics
  • Patient Skin Preparation Market
  • Environment Sterilization
  • Air Treatment
  • Room Filtration Systems
  • Room Pressurization
  • UV Light Disinfection
  • Water Treatment
  • Equipment/Facility Sterilization
  • Heat Sterilization
  • Chemical Sterilization
  • Radiation-based Sterilization
  • Environment Sterilization Market

Chapter 7 Medical Devices

  • HCAI: Medical Devices Market
  • Antimicrobial Coatings
  • Catheters
  • Patient Ventilation Devices
  • Types of Ventilation Devices
  • IV Filters
  • IV Filter Market

Chapter 8 Industry Structure

  • Industry Structure for Healthcare Infection Prevention
  • Suppliers
  • Customers
  • Consumers

Chapter 9 Research and Opportunities

  • New Technologies
  • Hand Hygiene
  • Patient Tracing
  • Self-Disinfecting Surfaces
  • Automated Decontamination Technologies
  • Smart Systems and Predictive Analytics
  • Other Technologies
  • Antibiotics Pipeline
  • Viral Infection Pipeline -- Hepatitis B and Hepatitis C
  • Pipeline of Viral Infection Influenza
  • Fungal Infection Pipeline

Chapter 10 Patent Analysis

  • Pharmaceuticals
  • Antibiotics
  • Hepatitis B
  • Hepatitis C
  • Influenza
  • Antifungals
  • Environment Sterilization
  • Disinfectants
  • Patient Skin Preparation
  • Air Treatment
  • Water Treatment
  • Medical Devices
  • Catheters and Endotracheal Tubes
  • IV Filters (In-Line)

Chapter 11 Company Profiles

  • Pharmaceutical Companies
  • Gilead Sciences
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi, Sanofi Pasteur
  • Seqirus
  • Companies In Sterilization/Disinfection Industry
  • 3M Healthcare
  • Advanced Sterilization Products
  • Becton, Dickinson And Company
  • Belimed
  • Sterigenics
  • The Clorox Company
  • Xenex Disinfection Services
  • Medical Device Companies
  • Bactiguard
  • Teleflex

Chapter 12 Appendix

List of Tables
Summary Table A: Global Market for HCAI Control, by Segment, Through 2023
Summary Table B: Global Market for HCAI Control, by Region, Through 2023
Table 1: Pooled Cumulative Incidence Density, HCAI and Device-Associated Infections in Adults, 1995-2010
Table 2: HCAIs, LTACHs and IRFs in the U.S., 2014
Table 3: SSI Rates for Select Procedures, U.S., 2014
Table 4: Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
Table 5: Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
Table 6: Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
Table 7: Routine Prevention of Waterborne Microbial Contamination Within the Distribution System, CDC Recommendations, Updated February 2017
Table 8: Proportion of Resistant Strains, by WHO Region
Table 9: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 10: Administrative Measures, MDROs, CDC Recommendations, Updated 2006
Table 11: Education and Training, MDROs, CDC Recommendations, Updated 2006
Table 12: Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
Table 13: Surveillance, MDROs, CDC Recommendations, Updated 2006
Table 14: Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
Table 15: Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
Table 16: Summary of Recommendations, CRBSI, CDC, Updated 2011
Table 17: SSI, CDC Recommendations, Updated 2017
Table 18: Dialysis, CDC Recommendations, Updated 2016
Table 19: Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAI, WHO Recommendations, Updated 2016
Table 20: Surveillance Elements and Methodology, CDC, Updated 2006
Table 21: Global Market for HCAI Control, by Segment, Through 2023
Table 22: Global Market for HCAI Control, by Region, Through 2023
Table 23: Global Market for HCAI Pharmaceuticals, by Category, Through 2023
Table 24: Proportion of Resistant Strains, by WHO Region
Table 25: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 26: Select Branded Antibiotics, by Manufacturer
Table 27: Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2023
Table 28: Global Market for HCAI Antibiotics, by Region, Through 2023
Table 29: Select Branded Antifungals, by Manufacturer
Table 30: Global Market for HCAI Antifungals, by Class, Through 2023
Table 31: Global Market for HCAI Antifungals, by Region, Through 2023
Table 32: Key Marketed Hepatitis B Drugs
Table 33: Global Market for Hepatitis B Therapeutics for HCAI, by Region, Through 2023
Table 34: Global Market for Hepatitis B Vaccines for HCAI, by Region, Through 2023
Table 35: Key Marketed Hepatitis C Drugs
Table 36: Global Market for Hepatitis C Therapeutics for HCAI, by Region, Through 2023
Table 37: Key Marketed Influenza Vaccines
Table 38: Key Marketed Antivirals for Influenza
Table 39: Global Market for Influenza Vaccines for HCAI, by Region, Through 2023
Table 40: Global Market for HCAI Environment Treatment, by Category, Through 2023
Table 41: Select Branded Disinfectants, by Manufacturer
Table 42: Global Market for Disinfectant Use in Hospitals, by Region, Through 2023
Table 43: Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
Table 44: Global Market for Presurgical Skin Preparation, by Region, Through 2023
Table 45: Global Market for Air-Filtration for Hospital Use, by Region, Through 2023
Table 46: Global Market for High-Temperature Sterilization, by Region, Through 2023
Table 47: Global Market for Low-Temperature Sterilization, by Category, Through 2023
Table 48: Global Market for Low-Temperature Sterilization, by Region, Through 2023
Table 49: Global Market for Radiation-based Sterilization, by Category, Through 2023
Table 50: Global Market for Radiation-based Sterilization, by Region, Through 2023
Table 51: Global Market for HCAI Medical Devices, by Category, Through 2023
Table 52: Global Market for Coated Catheter, by Category, Through 2023
Table 53: Global Market for Coated Catheter, by Region, Through 2023
Table 54: Global Market for Coated Endotracheal Tube, by Region, Through 2023
Table 55: Global Market for IV Filter, by Region, Through 2023
Table 56: Global Antibiotics Development Pipeline
Table 57: Hepatitis B and Hepatitis C Clinical Pipeline
Table 58: Influenza A and Influenza B Clinical Pipeline
Table 59: Antifungal Clinical Pipeline
Table 60: Number of Published Patent Applications for Antibiotics, 2014-2017
Table 61: Number of Published Patent Applications for Hepatitis B, 2014-2017
Table 62: Number of Published Patent Applications for Hepatitis C, 2014-2017
Table 63: Number of Published Patent Applications for Influenza, 2014-2017
Table 64: Number of Published Patent Applications for Antifungals, 2014-2017
Table 65: Number of Published Patent Applications for Disinfectants, 2014-2017
Table 66: Number of Published Patent Applications for Patient Skin Preparation, 2014-2017
Table 67: Number of Published Patent Applications for Air Treatment, 2014-2017
Table 68: Number of Published Patent Applications for Water Treatment, 2014-2017
Table 69: Number of Published Patent Applications for Catheters and ETTs, 2014-2017
Table 70: Abbreviations Used in Global Markets for Infectious Diseases
Table 71: Glossary of Terms Used in Global Markets for Infectious Diseases
Table 72: Report Sources

List of Figures
Summary Figure A: Global Market for HCAI Control, by Segment, 2017-2023
Summary Figure B: Global Market for HCAI Control, by Region, 2017-2023
Figure 1: Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 2: Global Market for HCAI Control, by Segment, 2017-2023
Figure 3: Global Market for HCAI Control, by Region, 2017-2023
Figure 4: Global Market for HCAI Pharmaceuticals, by Category, 2017-2023
Figure 5: Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 6: Global Market for HCAI Antibiotics, by Class (ATC Code), 2017-2023
Figure 7: Global Market for HCAI Antibiotics, by Region, 2017-2023
Figure 8: Global Market for HCAI Antifungals, by Class, 2017-2023
Figure 9: Global Market for HCAI Antifungals, by Region, 2017-2023
Figure 10: Global Market for Hepatitis B Therapeutics for HCAI, by Region, 2017-2023
Figure 11: Global Market for Hepatitis B Vaccines for HCAI, by Region, 2017-2023
Figure 12: Global Market for Hepatitis C Therapeutics for HCAI, by Region, 2017-2023
Figure 13: Global Market for Influenza Vaccines for HCAI, by Region, 2017-2023
Figure 14: Global Market for HCAI Environment Treatment, by Category, 2017-2023
Figure 15: Global Market for Disinfectant Use in Hospitals, by Region, 2017-2023
Figure 16: Global Market for Presurgical Skin Preparation, by Region, 2017-2023
Figure 17: Global Market for Air-Filtration for Hospital Use, by Region, 2017-2023
Figure 18: Global Market for High-Temperature Sterilization, by Region, 2017-2023
Figure 19: Global Market for Low-Temperature Sterilization, by Category, 2017-2023
Figure 20: Global Market for Low-Temperature Sterilization, by Region, 2017-2023
Figure 21: Global Market for Radiation-based Sterilization, by Category, 2017-2023
Figure 22: Global Market for Radiation-based Sterilization, by Region, 2017-2023
Figure 23: Global Market for HCAI Medical Devices, by Category, 2017-2023
Figure 24: Global Market for Coated Catheter, by Category, 2017-2023
Figure 25: Global Market for Coated Catheter, by Region, 2017-2023
Figure 26: Global Market for Coated Endotracheal Tube, by Region, 2017-2028
Figure 27: Global Market for IV Filter, by Region, 2017-2023
Figure 28: HCAI-Prevention Industry Structure

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Healthcare
  • Advanced Sterilization Products
  • Bactiguard
  • Becton, Dickinson and Company
  • Belimed
  • Gilead Sciences
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi, Sanofi Pasteur
  • Seqirus
  • Sterigenics
  • Teleflex
  • The Clorox Company
  • Xenex Disinfection Services
Note: Product cover images may vary from those shown
Adroll
adroll